Inovio Pharmaceuticals Inc (NAS:INO)
$ 11.11 -0.89 (-7.42%) Market Cap: 287.87 Mil Enterprise Value: 218.74 Mil PE Ratio: 0 PB Ratio: 2.75 GF Score: 48/100

Q2 2020 Inovio Pharmaceuticals Inc Earnings Call Transcript

Aug 10, 2020 / 08:30PM GMT
Release Date Price: $227.88 (-6.08%)
Operator

Good day, and welcome to the Inovio Second Quarter 2020 Financial Results Conference Call. (Operator Instructions) Please note this event is being recorded.

I would now like to turn the conference over to Ben Matone, Senior Director of Investor Relations. Please go ahead.

Ben Matone
Inovio Pharmaceuticals, Inc. - Director of IR

Thank you, operator. Good afternoon, and thank you for joining Inovio's Second Quarter 2020 Earnings Conference Call. Joining us today are Dr. J. Joseph Kim, President and CEO; Dr. Kate Broderick, Senior Vice President of Research and Development and Project Lead for Inovio's infectious disease programs; Dr. Jacqui Shea, Inovio's Chief Operating Officer; and the company's Chief Financial Officer, Peter Kies.

For today's call, we will review our corporate and financial information for the second quarter 2020 ended June 30, 2020, as well as provide an update on our clinical programs progress, which includes the accelerated development for our COVID-19 vaccine program. This call is being webcast live on our website, ir

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot